Browsing by Author González-Martín, A. (Antonio)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleTypeAuthor(s)
2021A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA TrialArticuloSánchez-Lorenzo, M. L. (María Luisa); González-Martín, A. (Antonio); Colombo, N. (Nicoletta); dePont-Christensen, R. (René); Heitz, F. (Florian); Meirovitz, M. (Mihai); Selle, F. (Frederic); van Gorp, T. (Toon); Alvarez, N. (Nuria); Sánchez, J. (Javier); Marqués, C. (Carmen)
2019Chemotherapy-free treatments: are we ready for prime time?ArticuloLorusso, D. (D.); Pignata, S. (S.); González-Martín, A. (Antonio)
2019Cost–utility analysis of germline BRCA1/2 testing in women with high‑grade epithelial ovarian cancer in SpainArticuloMoya‑Alarcón, C. (Carlota); González‑Domínguez, A. (Almudena); Simón, S. (Susana); Pérez‑Román, I. (Inés); González-Martín, A. (Antonio); Bayo‑Lozano, E. (Eloisa); Sánchez‑Heras, A.B. (Ana Beatriz)
2020Efficacy of individualised starting dose (isd) and fixed starting dose (fsd) of niraparib per investigator assessment (ia) in newly diagnosed advanced ovarian cancer (oc) patientsArticuloPeen, U. (Ulla); Graybill, W. (Whitney); González-Martín, A. (Antonio); Omalley, D. (David); Baurain, J.F. (J. F.); Prendergast, E. (Emily); Follana, P. (Philippe); Braicu, E.I. (Elena Ioana); Gupta, D. (Dyvia); Monk, B.J. (Bradley J.)
2020ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignanciesArticuloColombo, I. (Ilaria); Zaccarelli, E. (Eleonora); Del Grande, M. (Maria); Tomao, F. (Federica); Multinu, F. (Francesco); Betella, I. (Ilaria); Ledermann, J.A. (Jonathan A.); González-Martín, A. (Antonio); Sessa, C. (Cristiana); Colombo, N. (Nicoletta)
2019Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancerArticuloGonzález-Martín, A. (Antonio); Oza, A.M. (Amit M.); Embleton, A.C. (Andrew C.); Pfisterer, J. (Jacobus); Ledermann, J.A. (Jonathan A.); Pujade-Lauraine, E. (Eric); Kristensen, G. (Gunnar); Bertrand, M.A. (Monique A.); Beale, P. (Philip); Cervantes, A. (Andrés); Kent, E. (Emma); Kaplan, R.S. (Richard S.); Parmar, M.K.B. (Mahesh K.B.); Scotto, N. (Nana); Perren, T.J. (Timothy J.); ICON7 investigators
2014First-Line and Maintenance Therapy for Ovarian Cancer: Current Status and Future DirectionsArticuloSánchez-Lorenzo, M. L. (María Luisa); González-Martín, A. (Antonio); Bratos, R. (Raquel); Márquez, R. (Raúl); Chiva, L. (Luis)
2020First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussionArticuloBanerjee, S. (S.); González-Martín, A. (Antonio); Harter, P. (P.); Lorusso, D. (D.); Moore, K.N. (Kathleen N.); Oaknin, A. (Ana); Ray-Coquard, I. (Isabelle)
2019GEICO1601-ROLANDO: a multicentric single arm Phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancerArticuloPerez-Fidalgo, J.A. (José Alejandro); Iglesias, M. (Maria); Bohn, U. (Uriel); Calvo, E. (E.); Garcia, Y. (Yolanda); Guerra-Alia, E. (Eva); Manso, L. (Luis); Santaballa, A. (Ana); González-Martín, A. (Antonio)
2018HIPEC: HOPE or HYPE in the fight against advanced ovarian cancer?ArticuloFotopoulou, C. (C.); Sehouli, J. (J.); Mahner, S. (S.); Harter, P. (P.); Van-Nieuwenhuysen, E. (E.); González-Martín, A. (Antonio); Vergote, I. (I.); Chiva, I. (I.); Du-Bois, A. (A.)
2019Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?ArticuloSánchez-Lorenzo, M. L. (María Luisa); González-Martín, A. (Antonio)
2020PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancerArticuloRischin, D. (Danny); Gil-Martin, M. (Marta); González-Martín, A. (Antonio); Braña, I. (Irene); Hou, J.Y. (June Y.); Cho, D. (Daniel); Falchook, G.S. (Gerald S.); Formenti, S.C. (Silvia C.); Jabbour, S. (Salma); Moore, K. (Kathleen); Naing, A. (Aung); Papadopoulos, K.P. (Kyriakos P.); Baranda, J. (Joaquina); Fury, W. (Wen); Feng, M. (Minjie); Stankevich, E. (Elizabeth); Li, J. (Jingjin); Yama-Dang, N.A. (N. Alice); Yoo, S.Y. (Suk-Young); Lowy, I. (Israel); Mathias, M. (Melissa); Fury, M.G. (Matthew G.)
2022Prospective Real-World Gynaecological Cancer Clinical Registry with Associated Biospecimens: A Collaborative Model to Promote Translational Research between GEICO and the Spanish Biobank NetworkArticuloSánchez-Lorenzo, M. L. (María Luisa); López-Guerrero, J.A. (José Antonio); Mendiola, M. (Marta); Perez-Fidalgo, J.A. (José Alejandro); Romero, I. (Ignacio); Torres, A. (Ana); Recalde, D. (Delia); Molina, E. (Elena); Gómez-Raposo, C. (César); Levin, A. M. (Ana M.); Herrero, A.B. (Ana B.); Alarcón, J. (Jesús); Esteban, C. (Carmen); Marquina, G. (Gloria); Rubio, M. J. (María Jesús); Guerra-Alia, E. (Eva); Gálvez-Montosa, F. (Fernando); de Juan, A. (Ana); Churruca, C. (Cristina); Gallego-Martínez, A. (Alejandro); González-Martín, A. (Antonio)
2022Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO studyArticuloSánchez-Lorenzo, M. L. (María Luisa); Yubero, A. (Alfonso); Barquín, A. (Aranzazu); Estévez, P. (Purificación); Pajares, B. (Bella); Reche, P. (Piedad); Alarcón, J. (Jesús); Calzas, J. (Julia); Gaba, L. (Lydia); Fuentes, J.A. (José Antonio); Santaballa, A. (Ana); Salvador, C. (Carmen); Manso, L. (Luis); Herrero, A.B. (Ana B.); Taus, A. (Álvaro); Márquez, R. (Raúl); Madani, J. (Julia); Merino, M. (María); Marquina, G. (Gloria); Casado, V. (Victoria); Constenla, M. (Manuel); Gutiérrez, M. (María); Dosil, A. (Alba); González-Martín, A. (Antonio)